Gene · 10892
Papers2,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells. | Leukemia | 2025 | 40425803 | PubTator, text mining | PubMed |
| Neuroendocrine characterization into schizophrenia: norepinephrine and melatonin as promising biomarkers. | Front Endocrinol (Lausanne) | 2025 | 40375951 | PubTator, text mining | PubMed |
| MALT1 inhibitor MI-2 induces ferroptosis by direct targeting of GPX4. | Proc Natl Acad Sci U S A | 2025 | 40343971 | PubTator, text mining | PubMed |
| Reply to Mishima et al.: MALT1 modulates GPX4 expression by regulating its stability. | Proc Natl Acad Sci U S A | 2025 | 40343970 | PubTator, text mining | PubMed |
| Positive Prognostic Overall Survival Impacts of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients. | Cancers (Basel) | 2025 | 40338274 | PubTator, text mining | PubMed |
| Downregulation of A20 Expression Related to T Cells by Staphylococcal Enterotoxin A Treatment. | Bull Exp Biol Med | 2025 | 40299129 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer. | Anticancer Res | 2025 | 40295064 | PubTator, text mining | PubMed |
| Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets. | Chem Res Toxicol | 2025 | 40253625 | PubTator, text mining | PubMed |
| A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma. | J Clin Invest | 2025 | 40231473 | PubTator, text mining | PubMed |
| An updated patent review of MALT1 inhibitors (2021-present). | Expert Opin Ther Pat | 2025 | 40209204 | PubTator, text mining | PubMed |
| Development and evaluation of an ovarian cancer prognostic model based on adaptive immune-related genes. | Medicine (Baltimore) | 2025 | 40193636 | PubTator, text mining | PubMed |
| The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment. | J Med Chem | 2025 | 40173276 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and therapeutic targets in psoriasis based on NF-κB pathway-related genes. | Arch Dermatol Res | 2025 | 40119934 | PubTator, text mining | PubMed |
| Targeting both death and paracaspase domains of MALT1 with antisense oligonucleotides overcomes resistance to immune-checkpoint inhibitors. | Nat Cancer | 2025 | 40075237 | PubTator, text mining | PubMed |
| Correction to: TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways. | Signal Transduct Target Ther | 2025 | 40038275 | PubTator, text mining | PubMed |
| MALT1 Inhibitors and Degraders: Strategies for NF-κB-Driven Malignancies. | J Med Chem | 2025 | 39999563 | PubTator, text mining | PubMed |
| Protective antibodies against enterotoxigenic Escherichia coli are generated from heat-labile toxoid vaccination and exhibit subject- and vaccine-specific diversity. | Med Microbiol Immunol | 2025 | 39934422 | PubTator, text mining | PubMed |
| EMZL at various sites: learning from each other. | Blood | 2025 | 39912633 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| CTHNet: A CNN-Transformer Hybrid Network for Landslide Identification in Loess Plateau Regions Using High-Resolution Remote Sensing Images. | Sensors (Basel) | 2025 | 39797065 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10892/papers?page=5